January 20th 2023
A look into the future of acute GvHD prevention and discussing the impact of targeting specific organs to help manage GvHD prevention.
Experts review the Phase III BMT CTN 1703 trial and share how the results of this trial might impact their practice and discuss the role of ATG and abatacept in their practice
January 13th 2023
A brief review of the different regimens used by experts for GvHD prevention at their institutions and discuss the importance of GvHD Prevention.
Expert oncologists define graft vs host disease (GvHD) and discuss which risk factors might increase a patient’s risk of developing GvHD.